Efficacy of Various Doses of Hydroxychloroquine in Pre-Exposure Prophylaxis for COVID 19
NCT04359537
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
200
Enrollment
OTHER
Sponsor class
Conditions
COVID 19
Interventions
DRUG:
Hydroxychloroquine Sulfate 200 MG
OTHER:
Placebo
Sponsor
Shaheed Zulfiqar Ali Bhutto Medical University